Afya Limited Stock Price, News & Analysis

Afya Limited (Nasdaq: AFYA) has announced the sale of 23,074,134 Class B common shares by Crescera Educacional to an affiliate of Bertelsmann SE & Co. KGaA. Bertelsmann has held a stake in Afya since inception through Crescera and had a representative on Afya’s board since 2019. Following the transaction, Crescera board members Daniel Borghi and Laura Guaraná have left, while Bertelsmann appointed Shobhna Mohn and Kay Krafft to the board. Mohn brings extensive VC experience, and Krafft has a background in M&A and strategic investments.

Afya Limited (Nasdaq: AFYA) has successfully closed the acquisition of Companhia Nilza Cordeiro Herdy de Eduação e Cultura (UNIGRANRIO) for an enterprise value of R$700 million, including R$73.9 million in net debt. The payment structure consists of 60% in cash and 40% in four annual installments. This acquisition enhances Afya's educational capacity, adding 308 medical school seats and increasing total medical seats to 2,611, projecting a net revenue of R$343.2 million for 2023. The acquisition is expected to boost margins and deliver a 9% CAGR in medical student enrollment by 2026.

Afya Limited (Nasdaq: AFYA) successfully held its Annual General Meeting on July 23, 2021, where shareholders approved key resolutions. These included the ratification of financial statements for the fiscal year ending December 31, 2020, and the approval of an Amended and Restated Memorandum and Articles of Association. These changes are in accordance with a share purchase agreement established on June 7, 2021, with Crescera Educacional II and Erste WV Gtersloh Gmbh. Afya is a prominent medical education group in Brazil, focusing on enhancing medical students' and physicians' experiences.

Afya Limited (Nasdaq: AFYA) is set to release its second quarter 2021 financial results on August 26, 2021, after market close. The subsequent conference call is scheduled for August 27 at 11:00 AM EDT.

This timely update follows the company's role as a major medical education provider in Brazil, underscoring its dedication to lifelong learning for medical professionals. The investor relations information can be accessed through their website.

The Annual General Meeting (AGM) of Afya Participações S.A. will be held on July 23, 2021, at 11:00 AM Brasilia time at its headquarters in Nova Lima, Brazil. Key resolutions include the approval of financial statements for the fiscal year ending December 31, 2020, and proposed amendments to the Memorandum and Articles of Association. Shareholders eligible to attend must be on record as of June 24, 2021. The Board recommends voting in favor of the resolutions. Shareholders may participate virtually and are encouraged to submit proxy forms in advance.

Afya Limited (Nasdaq: AFYA) announces the acquisition of 23,074,134 Class B common shares from Crescera Educacional by Bertelsmann. This strategic transaction allows Bertelsmann to enhance its influence in Afya, having held an indirect stake since inception. Following the acquisition, Bertelsmann can appoint three board members. The deal is pending antitrust approval and includes leadership adjustments, with Daulins Emílio reappointed and Paulo Passoni joining the board. The collaboration aims to strengthen Afya's position in the medical education sector.

Afya Limited (Nasdaq: AFYA) has closed its acquisition of Sociedade Padrão de Educação Superior Ltda (UNIFIPMoc and Fip Guanambi) for R$360 million, which includes R$31.1 million in net debt. This acquisition adds 160 medical school seats, increasing total seats to 2,303, potentially 2,611 with pending approvals. Net revenue for UNIFIPMoc was R$110 million in 2020, with a projection of R$121 million for 2024. The acquisition aims for an EV/EBITDA of 5.1x at maturity, enhancing Afya's position in Brazil's medical education sector.

Afya Limited (Nasdaq: AFYA) reported strong 1Q21 results, with adjusted net revenue rising 47.8% year-over-year to R$402.5 million and an adjusted EBITDA increase of 47.6% to R$207.7 million, maintaining a margin of 51.6%. The company experienced a significant rise in medical students, up 61.5% to 12,852. Notably, the digital business expanded by 43%, aided by strategic acquisitions, including UNIGRANRIO. Afya reaffirmed its guidance for 1H21, projecting net revenue between R$740 million and R$780 million, signaling positive growth expectations.

Afya announced its acquisition of 100% of Universidade do Grande Rio Professor José de Souza Herdy (UNIGRANRIO) for R$700 million. The payment structure includes 60% in cash and 40% in annual installments. UNIGRANRIO adds 308 medical school seats, raising Afya's total to 2,611, with a projected CAGR of 9% from 2020 to 2026. The projected net revenue for UNIGRANRIO in 2023 stands at R$343.2 million, largely from medical courses. This acquisition strengthens Afya’s presence in Rio de Janeiro and enhances its position in the medical education sector.